These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 30479468

  • 21. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
    Topstad DR, Panaccione R, Heine JA, Johnson DR, MacLean AR, Buie WD.
    Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
    [Abstract] [Full Text] [Related]

  • 22. Surgical management of complex perianal fistula revisited in a systematic review: a critical view of available scientific evidence.
    García-Olmo D, Gómez-Barrera M, de la Portilla F.
    BMC Surg; 2023 Feb 05; 23(1):29. PubMed ID: 36740680
    [Abstract] [Full Text] [Related]

  • 23. Allogeneic adipose-derived stem cells for the treatment of perianal fistula in Crohn's disease: a pilot clinical trial.
    Park KJ, Ryoo SB, Kim JS, Kim TI, Baik SH, Kim HJ, Lee KY, Kim M, Kim WH.
    Colorectal Dis; 2016 May 05; 18(5):468-76. PubMed ID: 26603576
    [Abstract] [Full Text] [Related]

  • 24. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial.
    de la Portilla F, Alba F, García-Olmo D, Herrerías JM, González FX, Galindo A.
    Int J Colorectal Dis; 2013 Mar 05; 28(3):313-23. PubMed ID: 23053677
    [Abstract] [Full Text] [Related]

  • 25. Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn's Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial.
    Garcia-Olmo D, Gilaberte I, Binek M, D Hoore AJL, Lindner D, Selvaggi F, Spinelli A, Panés J.
    Dis Colon Rectum; 2022 May 01; 65(5):713-720. PubMed ID: 34890373
    [Abstract] [Full Text] [Related]

  • 26. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR, Ficari F, Bagnoli S, Milla M, Tonelli F.
    Scand J Gastroenterol; 2006 Sep 01; 41(9):1064-72. PubMed ID: 16938720
    [Abstract] [Full Text] [Related]

  • 27. Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease.
    Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Diez MC, Tagarro I, Leselbaum A, Danese S, ADMIRE CD Study Group Collaborators.
    Gastroenterology; 2018 Apr 01; 154(5):1334-1342.e4. PubMed ID: 29277560
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial.
    Meima-van Praag EM, van Rijn KL, Wasmann KATGM, Snijder HJ, Stoker J, D'Haens GR, Gecse KB, Gerhards MF, Jansen JM, Dijkgraaf MGW, van der Bilt JDW, Mundt MW, Spinelli A, Danese S, Bemelman WA, Buskens CJ.
    Lancet Gastroenterol Hepatol; 2022 Jul 01; 7(7):617-626. PubMed ID: 35427495
    [Abstract] [Full Text] [Related]

  • 30. The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease.
    Haennig A, Staumont G, Lepage B, Faure P, Alric L, Buscail L, Bournet B, Moreau J.
    Colorectal Dis; 2015 Apr 01; 17(4):311-9. PubMed ID: 25425534
    [Abstract] [Full Text] [Related]

  • 31. Statement of the polish expert group on the current practice and prospects for the treatment of complex perianal fistulas in Crohn's disease. Update 2021.
    Banasiewicz T, Eder P, Rydzewska G, Reguła J, Dobrowolska A, Durlik M, Wallner G, Dziki A.
    Pol Przegl Chir; 2021 Aug 31; 93(4):70-79. PubMed ID: 34515655
    [Abstract] [Full Text] [Related]

  • 32. Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.
    Barnhoorn MC, Wasser MNJM, Roelofs H, Maljaars PWJ, Molendijk I, Bonsing BA, Oosten LEM, Dijkstra G, van der Woude CJ, Roelen DL, Zwaginga JJ, Verspaget HW, Fibbe WE, Hommes DW, Peeters KCMJ, van der Meulen-de Jong AE.
    J Crohns Colitis; 2020 Jan 01; 14(1):64-70. PubMed ID: 31197361
    [Abstract] [Full Text] [Related]

  • 33. Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease.
    Garcia-Olmo D, Garcia-Arranz M, Herreros D.
    Expert Opin Biol Ther; 2008 Sep 01; 8(9):1417-23. PubMed ID: 18694359
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Update on the Natural Course of Fistulizing Perianal Crohn's Disease in a Population-Based Cohort.
    Park SH, Aniwan S, Scott Harmsen W, Tremaine WJ, Lightner AL, Faubion WA, Loftus EV.
    Inflamm Bowel Dis; 2019 May 04; 25(6):1054-1060. PubMed ID: 30346531
    [Abstract] [Full Text] [Related]

  • 39. Darvadstrocel: A Review in Treatment-Refractory Complex Perianal Fistulas in Crohn's Disease.
    Scott LJ.
    BioDrugs; 2018 Dec 04; 32(6):627-634. PubMed ID: 30298387
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.